Description
Cisplatina Accord (cisplatin) Concentrate for Infusions 1 mg/ml – 50 ml – №1 Vial
Ingredients:
Each ml contains 1 mg of cisplatin as the active ingredient.
Mechanism of Action:
Cisplatin exerts its antitumor effects by forming cross-links with DNA, leading to cell death. It is particularly effective against rapidly dividing cells, making it a cornerstone in the treatment of various cancers.
Indications for Use:
Cisplatina Accord is indicated for the treatment of various types of cancers, including testicular, ovarian, bladder, and lung cancers. It works by interfering with the growth of cancer cells.
Contraindications:
Do not use Cisplatina Accord if you have a history of allergic reactions to cisplatin or similar drugs. It is contraindicated in patients with severe kidney problems.
Side Effects:
Possible side effects of Cisplatina Accord may include nausea, vomiting, and hair loss. Patients should report any side effects to their healthcare provider.
Usage Instructions:
The dosage of Cisplatina Accord should be calculated based on the patient’s body surface area and renal function. It is administered intravenously under the supervision of a healthcare professional. Follow the instructions provided by your healthcare provider for the proper administration of Cisplatina Accord. It is essential to stay hydrated during and after treatment.
Benefits Compared to Analogues:
Cisplatin has been shown to be highly effective in treating various cancers, with studies demonstrating its role in improving survival rates in patients with testicular and ovarian cancer compared to other treatment options.
Suitable Patient Groups:
Cisplatina Accord can be used in various patient groups, including adults, children, and the elderly, under appropriate medical supervision.
Storage and Shelf Life:
Store Cisplatina Accord as per the instructions provided on the packaging. Check the expiration date and do not use expired medication.
Packaging Description:
Cisplatina Accord is available in vials containing 50 ml of concentrate for infusion.
Clinical Evidence and Proven Effectiveness:
Clinical studies have shown that cisplatin-based chemotherapy regimens are highly effective in the management of testicular cancer. Additionally, studies have demonstrated the role of cisplatin in improving survival rates in patients with ovarian cancer.
